baber/WOPTO huggingface dataset:
Patent AU-2013201060-A1 (AU)
Title: Filter plate and process for filtering a suspension
Inventor: BONN HEINZ
IPC: B01D25/127
Filed: 2013-02-21
Abstract: FILTER PLATE AND PROCESS FOR FILTERING A SUSPENSION The invention relates to a filter plate (1) with at least one filling shoe (2, 2'). According to the invention it is characterised by the filling shoe (2, 2') having a drive (4, 7, 18). In addition, the invention relates to a process for filtering a suspension, which is fed through at least one filling shoe (2, 2') into at least one filter chamber formed between a filter plate and a counterplate of a filter device, where a filter cake forms on a filter cloth (8) on the filter plate (1), where the filter device is opened, and where the at least one filling shoe (2, 2') is lifted subsequently off the filter cloth (8) by means of the drive (4, 7, 18) and the filter cloth (8) is conveyed onwards. By using a drive to move the filling shoe, the time at which the filling shoe is lifted off the filter cloth can be selected such that the filling shoe suffers no damage, and the filter cloth clamping can also be opened after two or more filtration cycles and the filter cloth conveyed further onwards if this is possible with the products to be filtered. (0 0
Patent AU-2013203683-A1 (AU)
Title: Methods and apparatus to identify media
Inventor: MCMILLAN GAVIN
IPC: G06V30/224
Filed: 2013-04-11
Abstract: METHODS AND APPARATUS TO IDENTIFY MEDIA Methods and apparatus for identifying media are described. An example method includes determining application identification information for a media presentation application executing on a media device, determining a first watermark for the application identification information from a lookup table, requesting media identification information for media from the media presentation application, determining a second watermark for the media identification information from the lookup table, inserting the first watermark in the media prior to output of the media by the media device, and inserting the second watermark in the media prior to the output of the media by the media device. First Named Inventor: Gavin McMillan Attorney Docket No. 20004/80267US01 FACILITY MEDIA 110 PROVIDER 102--l IDENTIFICATION API MEDIA GENERATOR 121 APPLICATION 126 --- 120 WATERMARK RENDERING GENERATOR 127 ENGINE
Patent AU-2013204401-A1 (AU)
Title: An Interactive Media Guidance System Having Multiple Devices
Inventor: ELLIS MICHAEL D
IPC: H04N7/173
Filed: 2013-04-12
Abstract: The present invention is directed to a method for recording programs in a group of user equipment devices connected over a network, the method comprising: receiving a selection of a program for recording using an interactive media guidance application on a first user equipment device of the group; determining with the interactive media guidance application a user equipment device of the group where the program is to be recorded based on which user equipment device in the group has the most resources or capacity; and recording the selected program on the determined user equipment device.
Patent AU-2013207640-A1 (AU)
Title: Improved Vehicle Stand
Inventor: SHEPHARD ANDREW JOHN
IPC: B60S9/04
Filed: 2013-07-19
Abstract: Abstract The invention is an adjustable support of the type having a base upon which the support stands, and an outer elongate tubular member and an inner elongate member 5 that is capable of freely sliding within the outer elongate tubular member, thereby permitting the manual adjustment of the support's height by the user. The outer elongate member is attached to the base and rises vertically upwardly from the base. The outer elongate tubular member has a plurality of holes at spaced intervals along its length. The inner elongate member has a single hole at a position along its length 10 so that the hole on the inner elongate member can be manually manipulated to align with a user selected hole from the plurality of holes on the outer elongate member. A pin can then be inserted into the aligned holes of the inner and outer elongate members to pin the inner elongate member in place relative to the outer elongate member.
Patent AU-2013213660-A1 (AU)
Title: Method for printing an upscaled image
Inventor: WARREN STUART JAMES
IPC: G06T3/40
Filed: 2013-08-06
Abstract: - 35 Abstract METHOD FOR PRINTING AN UPSCALED IMAGE Disclosed is a method (200) of printing a transformed image corresponding to a source image. The method determines (210) at least a first scale factor to upscale the source image to generate the transformed image, the first scale factor being at a first mathematical precision. The source image is enlarged (240,250) along at least one edge of said source image edges and pixel data is copied (270) along the source image edges into the enlarged area of the enlarged source image. The method maps (280) each pixel of the transformed image back to a corresponding pixel into the enlarged source image including the copied pixel data along the edge of the source image. The method may determine (230) a second scale factor, the second scale factor being at a second mathematical precision, wherein each pixel of the transformed image is mapped back to a corresponding pixel in the enlarged source image using the second scale factor. 770iS44 1 PO711RR snpri Indged Start Compute image transform Adjust image transform 230 Compute inverse transform in different mathematical precision Determine size of buffer Allocate buffer in display list 260 Copy image data into buffer taking into account enlarged region 270 Copy image data into enlarged region of buffer Map pixels Fig. 2 (:End
Patent AU-2013218367-A1 (AU)
Title: Biodegradable non-woven material for medical purposes
Inventor: VOGT SEBASTIAN
IPC: A61L26/00
Filed: 2013-01-23
Abstract: The invention relates to a biodegradable non-woven material containing (i) at least one polymer for inducing primary haemostasis, (ii) at least one non-proteinogenic, water-soluble secondary haemostasis activator having a low molecular weight, and (iii) at least one non-proteinogenic, water-soluble fibrinolysis inhibitor having a low molecular weight. The invention also relates to a method for producing a biodegradable non-woven material, wherein (i) a fluidised raw fibre material is placed in a container, optionally along with additives, (ii) the container is set in rotation, (iii) the fluidised raw fibre material is discharged from the container by means of centrifugal forces, as a result of which fibres or filaments are formed, and (iv) a biodegradable non-woven material is formed from the fibres or filaments. The invention also relates to the use of such a biodegradable non-woven material as a local haemostatic agent.
Patent AU-2013229416-A1 (AU)
Title: miRNA based treatment monitoring in multiple sclerosis
Inventor: KELLER ANDREAS
IPC: C12Q1/68
Filed: 2013-03-07
Abstract: The present invention relates to methods of determining whether a patient responds to a therapeutic treatment of multiple sclerosis (MS), of monitoring the course of multiple sclerosis (MS) in a patient, of determining the risk for a relapse of multiple sclerosis (MS) in a patient, and of adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient. Said methods are based on the determination of the level of at least one miRNA in a test sample isolated from the patient. The present invention also relates to a method of identifying a compound suitable for the treatment of multiple sclerosis in a patient. Further, the present invention relates to the use of a polynucleotide or a polynucleotide set for detecting a miRNA to determine whether a patient responds to a therapeutic treatment of multiple sclerosis, to monitor the course of multiple sclerosis in a patient, to determine the risk of a relapse of multiple sclerosis in a patient, to adjust the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient, and to identify a compound suitable for the treatment of multiple sclerosis in a patient. Furthermore, the present invention relates to a kit for determining whether a patient responds to a therapeutic treatment of multiple sclerosis, for monitoring the course of multiple sclerosis in a patient, for determining the risk of a relapse of multiple sclerosis in a patient, for adjusting the dose of a therapeutic drug applied for therapeutic treatment of multiple sclerosis in a patient, or for identifying a compound suitable for the treatment of multiple sclerosis in a patient comprising means for determining the level of at least one miRNA in a test sample isolated from a patient.
Patent AU-2013231086-A1 (AU)
Title: Trailed agricultural implement pump with hydraulic flow rate control
Inventor: ENGELBRECHT JOSHUA J
IPC: A01C23/00
Filed: 2013-09-19
Abstract: Abstract of the Disclosure A trailed agricultural implement is disclosed. The trailed agricultural implement includes a hydrauially-driven pump for moving a fluid at an actual fluid rate. An electro-hydraulic valve is configured to regulate an implement hydraulic pressure to the hydraulica ly-driven pump. The hydraulically-driven pump regulates the actual fluid rate. The electro-hydraulic valve is configured to receive a vehicle hydraulic pressure. The electro-hydraulic valve communicates with a vehicle load sense system. The load sense system senses the implement hydraulic pressure and communicates with a vehicle hydraulic pump. The vehicle hydraulic pump adjusts the vehicle hydraulic pressure to correspond to the implement hydraulic pressure. C:) CN U') CV) --u -------------- --- --- RW7 LO cli o 0. (D U-
Patent AU-2013242865-A1 (AU)
Title: Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
Inventor: RAINES DOUGLAS
IPC: A61P23/00
Filed: 2013-10-11
Abstract: The invention is directed to compounds according to formula (I): R3 - \ R2 (I) where R1 is LiC(O)OT or LiC(O)OL 2C(O)OT; R2 is a substituted or unsubstituted C1-Cio alkyl, C2-Cio alkenyl, or C2-Cio alkynyl, or R1 ; n is an integer from 0 to 5; each R 3 is independently halogen or R2; Li and L 2 are each independently a bond, a substituted or unsubstituted C1-Cio alkylene, C2-Cio alkenylene, or C2-Cio alkynylene; and T is H, a substituted or unsubstituted C1-Cio alkyl, C2-Cio alkenyl, or C2-Cio alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
Patent AU-2013256795-A1 (AU)
Title: External reader for device management
Inventor: MCPHERSON JAMES W
IPC: A61B18/12
Filed: 2013-04-16
Abstract: A system for tracking use of a medical device including an electrosurgical generator, a readable module and a read module. The electrosurgical generator is configured to selectively deliver an electrosurgical energy signal to an electrosurgical delivery device connected to the electrosurgical generator. The readable module is connected to the electrosurgical delivery device and configured to uniquely identify the electrosurgical delivery device. The read module is in communication with the electrosurgical generator that identifies the read module, the read module configured to identify the readable module and further configured to determine the viability of the electrosurgical delivery device. Delivery of electrosurgical energy to the electrosurgical delivery device is enabled by the read module if the electrosurgical delivery device is a viable device.
Patent AU-2013270641-A1 (AU)
Title: Method for monitoring and measuring optical properties of device in polarization maintaining fibers by using reference fiber bragg grating and fiber components manufactured thereby
Inventor: ZHOU CHANGZUN
IPC: G02B6/024
Filed: 2013-12-16
Abstract: This invention provides a method for measuring and monitoring the state of 5 polarization (SOP) of a polarization maintaining (PM) fiber and the like using a narrowband fiber Bragg grating (FBG) written on the same. The PM fiber therefore comprises a first narrowband reference FBG which is used as a reference to measure and monitor the SOP of the PM fiber. Due to the birefringence properties of the PM fiber, the reference FBG will generally reflect two narrowband spectra, each having a 10 central wavelength; one in the slow axis and one in the fast axis. By measuring the intensity of the reflected spectra in each axis and by tuning the fiber with a polarization controller, it is possible to adjust the fiber to a predetermined SOP. After having adjusted the PM fiber to a predetermined SOP, it is possible to accurately measure the optical properties of a second grating, or of another optical device, 15 according to the predetermined SOP. The method of the present invention can also be advantageously used for accurate measurement of reflectivity. Figure 1 30 40 50 60 Figure 2
Patent AU-2013276565-A1 (AU)
Title: Tailored liposomes for the treatment of bacterial infections
Inventor: BABIYCHUCK EDUARD
IPC: A61K9/127
Filed: 2013-06-13
Abstract: The invention relates to the use of empty liposomes of defined lipid composition or mixtures of empty liposomes of defined lipid composition and to the use of other lipid bilayers or monolayers of defined lipid composition for the treatment and prevention of bacterial infections. It has been found that such liposomes, in particular a two-and a four- component mixture of liposomes comprising cholesterol and sphingomyelin, liposomes consisting of sphingomyelin, liposomes comprising sphingomyelin and phosphatidylcholine, and liposomes comprising cholesterol and phosphatidylcholine efficiently sequestrate a variety of toxins secreted by bacteria, thus preventing binding of bacterial toxins to target cells and toxin-induced lysis of the target cells. Injected intravenously, liposome mixtures prevented death of laboratory mice infected with lethal doses of Staphylococcus aureus or Streptococcus pneumoniae.
Patent AU-2013277582-A1 (AU)
Title: Reversible covalent pyrrolo- or pyrazolopyrimidines useful for the treatment cancer and autoimmune diseases
Inventor: GOLDSTEIN DAVID MICHAEL
IPC: A61K31/519
Filed: 2013-06-11
Abstract: Oral pharmaceutical formulations comprising reversible covalent compounds having a Michael acceptor moiety, a process of their production, and use of these formulations for the treatment of diseases treatable by such compounds such as cancer and autoimmune diseases.
Patent AU-2013284448-A1 (AU)
Title: Use of markers in the diagnosis and treatment of prostate cancer
Inventor: NARAIN NIVEN RAJIN
IPC: C12Q1/68
Filed: 2013-06-27
Abstract: The invention provides method for diagnosis, monitoring, and prognosis of prostate cancer using one or more of keratin 4, keratin 7, keratin 8, keratin 15, keratin 18, keratin 19, tubulin-beta 3, filamin B, and LY9, and PSA. The invention provides kits for practicing the methods of the invention.
Patent AU-2013309455-A1 (AU)
Title: A framework for networking and security services in virtual networks
Inventor: KAGANTY RAJU
IPC: H04L12/28
Filed: 2013-05-30
Abstract: Methods, computer-readable storage medium, and systems described herein facilitate registering and consuming network services on a virtual network. A virtual machine management server (VMMS) is configured to receive a service definition associated with a network service. The VMMS creates one or more service profiles based on the service definition. The VMMS configures a plurality of hosts based on the one or more service profiles such that the network service is usable, via a virtual network, by one or more virtual machines within the plurality of hosts.
Patent AU-2013317755-A1 (AU)
Title: Fire suppression systems and methods
Inventor: SANDAHL DEREK M
IPC: B60R16/03
Filed: 2013-09-23
Abstract: Fire suppression systems (10) for vehicles and industrial applications including arrangements of an input bus (24) and output bus (26) coupled to a centralized controller (20) to provide for automatic and manual detection of a fire (H) and manual and automatic system actuation in response to the fire. The arrangements further provide for system information regarding the status and operation of the system components. Additionally, the arrangement of system components provide for expandability and programmability to configure the system for the protection of multiple and variable hazards (H) using customized or programmed detection and/or actuation. The systems include configured connectors (25) and colour coded schemes to facilitate system installation.
Patent AU-2013320887-A1 (AU)
Title: Disposable diaper
Inventor: SAKAGUCHI SATORU
IPC: A61F13/15
Filed: 2013-09-27
Abstract: The disposable diaper (10) pertaining to the present invention is configured so that designs (300a, 300b) visible from the non-skin contacting surface side (S) of the disposable diaper (10) are provided in an area that extends to a front waistline region (20) and a back waistline region (30), straddling an inside-leg region (25), and that different methods are used to arrange the design (300b) provided to an area further toward the front waistline region (20) than the crotch elastic part (200a) and to arrange the design (300a) provided to an area further toward the back waistline region (30) than the crotch elastic part (200a).
Patent AU-2013323538-A1 (AU)
Title: Medical device design, manufacture and testing systems
Inventor: RAMACHANDRAN NIRAJ
IPC: G01N33/566
Filed: 2013-09-26
Abstract: Described are methods and systems for testing regions of medical devices, for example lumens of cannulated delivery components or assemblies thereof, that may be used to deliver cells to a patient or otherwise contact cells or cell preparations during use. Test cells are contacted with walls of the lumens or other device regions and/or liquids that contact walls of the lumens or other device regions, potentially over an incubation period. The test cells are then assessed for an effect of the wall contact, or the liquid contact, on at least one and preferably multiple characteristics of the test cells such as innate immune response, metabolic activity, viability, cytotoxic response, colony formation and/or motility. Methods and systems as described can be used in the development and/or manufacture of cannulated delivery devices or other medical device, for example providing specifications for design or process inputs or outputs, design or process validations, and/or device lot approvals. Also described are devices or products produced in accordance with such methods and systems.
Patent AU-2013330206-A1 (AU)
Title: Apparatus method and system for disintegration of a solid
Inventor: SPIROVSKI TONY
IPC: B01F11/02
Filed: 2013-10-04
Abstract: An apparatus for disintegration (or mixing) of a solid in a receptacle containing liquid, has a control unit and an ultrasound transducer generating ultrasonic energy under control of the control unit. An annular coupling element in communication with the ultrasound transducer is adapted to receive the receptacle. Ultrasonic energy is transferred to the receptacle contents through the annular coupling element. In use, the ultrasonic energy transferred to the receptacle contents causes disintegration of the solid into the liquid. A method for disintegration of a solid in a receptacle is also described.
Patent AU-2013341115-A1 (AU)
Title: Novel compounds as diacylglycerol acyltransferase inhibitors
Inventor: CHEUNG MUI
IPC: A61K31/501
Filed: 2013-11-08
Abstract: This invention relates to novel compounds which are inhibitors of acyl coenzyme A: diacylglycerol acyl transferase 1 (DGAT-1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination with other triglyceride lowering therapies for the prevention or treatment of diseases related to DGAT-1 dysfunction or where modulation of DGAT-1 activity may have therapeutic benefit including but not limited to obesity, obesity related disorders, genetic (Type 1, Type 5 hyperlipidemia) and acquired forms of hypertriglyceridemia or hyperlipoproteinemia related disorders, caused by but not limited to lipodystrophy, hypothyroidism, medications (beta blockers, thiazides, estrogen, glucocorticoids, transplant) and other factors (pregnancy, alcohol intake), hyperlipoproteinemia, chylomicronemia, dyslipidemia, non-alcoholic steatohepatitis, diabetes, insulin resistance, metabolic syndrome, cardiovascular outcomes, angina, excess hair growth (including syndromes associated with hirsutism), nephrotic syndrome, fibrosis such as mycocardial, renal and liver fibrosis, hepatitis C virus infection and acne or other skin disorders.
Patent AU-2013341212-A1 (AU)
Title: High solids enzyme reactor mixer with vertical paddle and method
Inventor: BOLZ EDWIN WILLIAM
IPC: C12M1/06
Filed: 2013-11-07
Abstract: A reactor vessel including: a mixing chamber having a vertical length, an upper inlet, and a lower outlet; and a vertically oriented paddle within the mixing chamber and having a cross-sectional shape of a hydrofoil, wherein the paddle moves with respect to the mixing chamber.
Patent AU-2013346489-A1 (AU)
Title: Method and apparatus for ion mobility spectrometry
Inventor: BLANKSBY STEPHEN J
IPC: H01J49/26
Filed: 2013-11-16
Abstract: Methods and systems for performing mass spectrometry are provided herein. The method includes ionizing one or more compounds to generate ions, passing the ions into an ion mobility spectrometer, providing ozone, reacting the ions with ozone to produce ozone-induced fragment ions, and performing mass analysis and detection of the ozone-induced fragment ions. The system can comprise an ion source for ionizing one or more compounds to generate ions, an ion mobility spectrometer for receiving and separating the ions, an ozone supply for introducing ozone into the system; a reaction region for reacting the ions with the ozone to produce ozone- induced fragment ions, and a mass spectrometer for performing mass analysis and detection of the ozone-induced fragment ions.
Patent AU-2013361382-A1 (AU)
Title: Hydrothermal hydrocatalytic treatment of biomass using water tolerant catalysts
Inventor: POWELL JOSEPH BROUN
IPC: B01J35/00
Filed: 2013-12-19
Abstract: A method of hydrothermal hydrocatalytic treating biomass is provided. Lignocellulosic biomass solids is provided to a hydrothermal digestion unit in the presence of a digestive solvent, and a supported hydrogenolysis catalyst containing (a) sulfur, (b) Mo or W, and (c) Co, Ni or mixture thereof, incorporated into an alumina support, which support is predominantly alpha alumina; (ii) heating the lignocellulosic biomass solids and digestive solvent in the presence of hydrogen, and supported hydrogenolysis catalyst thereby forming a product solution containing plurality of oxygenated hydrocarbons, said alumina support having a specific surface area of up to 30 m2/g and said catalyst retaining a crush strength of at least 50% after being subjected to an aqueous phase stability test compared with before the aqueous phase stability test or a crush strength of at least 0.25 kg after being subjected to an aqueous phase stability test.
Patent AU-2013393607-A1 (AU)
Title: Method for controlling a chain-link converter
Inventor: HASLER JEAN-PHILIPPE
IPC: H02J3/26
Filed: 2013-07-04
Abstract: The present disclosure relates to a method for controlling a chain-link power converter (1), said converter comprising three phase legs (2), each of which phase legs comprising a plurality of series-connected converter cells (3), each of the cells comprising a DC capacitor, the phase legs being connected in a delta configuration. The method comprises: detecting an unsymmetrical voltage condition at a terminal of the converter; determining a ratio between a zero sequence and a negative sequence component of a compound current to be injected into the converter, based on the detected unsymmetrical voltage condition; calculating the compound current comprising the zero sequence component and the negative sequence component in accordance with the determined ratio; and injecting the compound current into the converter to control the converter in view of the detected unsymmetrical voltage condition.